FDA regulatory designation allowing food additives and substances to skip formal approval if industry deems them safe based on common use or scientific consensus.
GRAS is a category created by the 1958 Food Additives Amendment that exempts substances from pre-market FDA approval if they achieve consensus recognition as safe among qualified experts. The FDA maintains a GRAS list, but the system also permits manufacturers to conduct internal GRAS determinations without FDA review, notifying the agency only after deciding a substance qualifies. This creates a self-certification pathway where companies evaluate their own ingredient safety claims.
Notable GRAS designations have proven controversial upon later scrutiny. High-fructose corn syrup received GRAS status in 1983 under the Reagan administration, despite growing epidemiological evidence linking it to metabolic dysfunction; it remained classified as GRAS through 2024 despite obesity epidemic correlation. More recently, titanium dioxide (E171), long GRAS-designated for food coloring, faced EU restrictions in 2022 over genotoxicity concerns, while the FDA maintained GRAS status. In 2023, the FDA questioned the GRAS status of brominated vegetable oil (BVO), originally approved in 1970, after decades of use in citrus-flavored beverages and subsequent animal studies suggesting liver toxicity.
Critics argue the GRAS loophole allows insufficient safety vetting because industry-funded research may lack independence, and the burden of proof falls on FDA to challenge designations rather than manufacturers to prove safety. The system reflects Cold War-era deregulatory assumptions that have persisted largely unchanged, creating gaps between corporate risk assessment and independent scientific validation.
